Resmed Inc’s filing revealed that its Chief Financial Officer Sandercock Brett unloaded Company’s shares for reported $0.24 million on Dec 09 ’24. In the deal valued at $244.23 per share,1,000 shares were sold. As a result of this transaction, Sandercock Brett now holds 93,864 shares worth roughly $21.7 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Sandercock Brett bought 1,000 shares, generating $244,230 in total proceeds.
Before that, FARRELL PETER C sold 2,000 shares. Resmed Inc shares valued at $491,300 were divested by the Director at a price of $245.65 per share. As a result of the transaction, FARRELL PETER C now holds 81,218 shares, worth roughly $18.78 million.
Stifel initiated its Resmed Inc [RMD] rating to a Hold in a research note published on December 13, 2024; the price target was $250. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in late September with a ‘”an Outperform”‘ rating. Wolfe Research also remained covering RMD and has decreased its forecast on September 18, 2024 with a “an Underperform” recommendation from previously “Peer perform” rating. Needham revised its rating on September 04, 2024. It rated RMD as “a Hold” which previously was an “a Buy”.
Price Performance Review of RMD
On Monday, Resmed Inc [NYSE:RMD] saw its stock fall -2.57% to $231.17. Over the last five days, the stock has lost -4.09%. Resmed Inc shares have risen nearly 34.39% since the year began. Nevertheless, the stocks have risen 32.24% over the past one year. While a 52-week high of $260.49 was reached on 10/25/24, a 52-week low of $164.12 was recorded on 01/04/24. SMA at 50 days reached $242.37, while 200 days put it at $220.19.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 226.45, which if violated will result in even more drops to 221.74. On the upside, there is a resistance level at 233.94. A further resistance level may holdings at 236.72. The Relative Strength Index (RSI) on the 14-day chart is 39.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.47, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.56%. Stochastics %K at 24.79% indicates the stock is a holding.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2024-11-29, dropping by -0.36 million shares to a total of 7.54 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 7.89 million shares. There was a decline of -4.73%, which implies that there is a negative sentiment for the stock.
